Skip to main content
NCBI home page
Heart logoLink to Heart
editorial
. 1996 Aug;76(2):103–104. doi: 10.1136/hrt.76.2.103

Genes, greens, and homocysteine.

R A Meleady, D A Mulcahy, I M Graham
PMCID: PMC484452  PMID: 8795467

Full text

PDF
103

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arnesen E., Refsum H., Bønaa K. H., Ueland P. M., Førde O. H., Nordrehaug J. E. Serum total homocysteine and coronary heart disease. Int J Epidemiol. 1995 Aug;24(4):704–709. doi: 10.1093/ije/24.4.704. [DOI] [PubMed] [Google Scholar]
  2. Boushey C. J., Beresford S. A., Omenn G. S., Motulsky A. G. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA. 1995 Oct 4;274(13):1049–1057. doi: 10.1001/jama.1995.03530130055028. [DOI] [PubMed] [Google Scholar]
  3. Daly L., Robinson K., Tan K. S., Graham I. M. Hyperhomocysteinaemia: a metabolic risk factor for coronary heart disease determined by both genetic and environmental influences? Q J Med. 1993 Oct;86(10):685–689. doi: 10.1093/qjmed/86.10.685. [DOI] [PubMed] [Google Scholar]
  4. Di Minno G., Davì G., Margaglione M., Cirillo F., Grandone E., Ciabattoni G., Catalano I., Strisciuglio P., Andria G., Patrono C. Abnormally high thromboxane biosynthesis in homozygous homocystinuria. Evidence for platelet involvement and probucol-sensitive mechanism. J Clin Invest. 1993 Sep;92(3):1400–1406. doi: 10.1172/JCI116715. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Harpel P. C., Chang V. T., Borth W. Homocysteine and other sulfhydryl compounds enhance the binding of lipoprotein(a) to fibrin: a potential biochemical link between thrombosis, atherogenesis, and sulfhydryl compound metabolism. Proc Natl Acad Sci U S A. 1992 Nov 1;89(21):10193–10197. doi: 10.1073/pnas.89.21.10193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Kang S. S., Wong P. W., Susmano A., Sora J., Norusis M., Ruggie N. Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease. Am J Hum Genet. 1991 Mar;48(3):536–545. [PMC free article] [PubMed] [Google Scholar]
  7. McCully K. S. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol. 1969 Jul;56(1):111–128. [PMC free article] [PubMed] [Google Scholar]
  8. Mudd S. H., Levy H. L. Plasma homocyst(e)ine or homocysteine? N Engl J Med. 1995 Aug 3;333(5):325–325. doi: 10.1056/NEJM199508033330520. [DOI] [PubMed] [Google Scholar]
  9. Pancharuniti N., Lewis C. A., Sauberlich H. E., Perkins L. L., Go R. C., Alvarez J. O., Macaluso M., Acton R. T., Copeland R. B., Cousins A. L. Plasma homocyst(e)ine, folate, and vitamin B-12 concentrations and risk for early-onset coronary artery disease. Am J Clin Nutr. 1994 Apr;59(4):940–948. doi: 10.1093/ajcn/59.4.940. [DOI] [PubMed] [Google Scholar]
  10. Stampfer M. J., Malinow M. R., Willett W. C., Newcomer L. M., Upson B., Ullmann D., Tishler P. V., Hennekens C. H. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA. 1992 Aug 19;268(7):877–881. [PubMed] [Google Scholar]
  11. Starkebaum G., Harlan J. M. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J Clin Invest. 1986 Apr;77(4):1370–1376. doi: 10.1172/JCI112442. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Wu L. L., Wu J., Hunt S. C., James B. C., Vincent G. M., Williams R. R., Hopkins P. N. Plasma homocyst(e)ine as a risk factor for early familial coronary artery disease. Clin Chem. 1994 Apr;40(4):552–561. [PubMed] [Google Scholar]

Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES